WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016

Globally, group B Streptococcus (GBS) remains a leading cause of sepsis and meningitis in infants in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for women at increased risk of transmitting GBS to their newborns has been effective in reducing part, but not all, of the GBS dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Miwako, Schrag, Stephanie J., Alderson, Mark R., Madhi, Shabir A., Baker, Carol J., Sobanjo-ter Meulen, Ajoke, Kaslow, David C., Smith, Peter G., Moorthy, Vasee S., Vekemans, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892266/
https://www.ncbi.nlm.nih.gov/pubmed/28017431
http://dx.doi.org/10.1016/j.vaccine.2016.12.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892266/
https://www.ncbi.nlm.nih.gov/pubmed/28017431
http://dx.doi.org/10.1016/j.vaccine.2016.12.029

Ejemplares similares